SEC Reporting & Technical Accounting Consultant

Entrada Therapeutics is seeking a consultant to provide interim, full-time support to the SEC Reporting & Technical Accounting function from mid-November 2026 through early March 2027. This role involves leading the preparation of the Company’s Form 10-K, managing the annual audit, and overseeing SOX 404(a) compliance while the Associate Director, SEC Reporting handles other responsibilities. The consultant will also manage technical accounting research, tax provisions, and accounting policies to ensure accurate and compliant financial reporting.